Abstract:
A detectoris described comprising a first graphene element (12), the first graphene element (12) comprising a few layer graphene element functionally doped with a dopant material and to which at least one electrode is connected.
Abstract:
An 'injection nozzle comprises a nozzle body defining an injection passage along which a material to be injected passes, in use, and a removable sensor body receivable within an opening formed in the nozzle body and having an opening formed therein which, in use, aligns with the injection passage such that material passing along the injection passage flows through the opening, the sensor body having at least one. probe mounted thereon and operable to permit sensing of a parameter of the material passing through the opening.
Abstract:
This invention relates to photonic biosensor arrays in particular employing plasmon resonance based sensing, and to methods and apparatus for reading such arrays. A biosensor array for plasmon resonance-based sensing of a plurality of different biological targets simultaneously, the array comprising a transparent substrate having a surface bearing a plurality of assay spots for plasmon resonance sensing, each of said assay spots comprising a discrete metallic island, a said metallic island comprising a plurality of metallic nanoparticles to which are attached functionalising molecules for binding to a said biological target, different said islands bearing different said functionalising molecules for binding to different ones of said biological targets, and wherein total internal reflection of light at said surface at a wavelength at or near a said plasmon resonance results in scattering of said light away from said surface, said scattering being modulated by said binding of said biological targets.
Abstract:
We describe a system/method for predicting the outcome of a medical procedure on a patient. The system/method uses using complement cascade data representing levels of a set of complement cascade markers in the patient at a succession of peri-operative time intervals, determining deviations from a model of the response to provide a pre-symptomatic prediction of the outcome. In embodiments the complement cascade pathways include the lytic pathway and at least one of the lectin pathway, the classical pathway and the alternative pathway, and the biomarkers include at least C3. The system may include an electroluminescence or plasmon-resonance multianalyte detector to analyse a blood sample from the patient.
Abstract:
A method of manufacturing an SMC material is described which comprises the steps of: (a) applying a resin material (18) to a first carrier film (16); (b) sprinkling recycled material fibres onto the resin material (18) and first carrier film (16); (c) sprinkling virgin material fibres (22) onto the resin material (18) and first carrier. film (16); and (d) sandwiching together the first carrier film (16) and a second carrier film (26) with the virgin and recycled material fibres located therebetween. Also described is an apparatus for distributing the recycled material fibres and an SMC material production line incorporating such an apparatus.
Abstract:
An additive layer manufacturing method comprising applying a material, for example a strong Raman scatterer material, treating the applied material using a laser 18, monitoring a characteristic of the applied material using a vibrational spectroscopy technique, for example a Raman technique, and using the output of the monitoring operation in controlling the treatment of the material. An apparatus for use in the method is also described.
Abstract:
This invention relates to devices, systems and methods for use in detecting a defect in a work piece. The device includes a transducer (10) comprising a piezoelectric crystal (11 ) mounted on a tungsten Epoxy backing (12). The transducer (10) is configured to operate in both receive and transmit modes. The transducers (10) can be used in various arrays, with various protocols for determining the mode of operation of any transducer at any particular time. The systems of signal analysis are described for determining the presence of the defect and, in certain cases, the nature of the defect.
Abstract:
A mooring limb for use in a fluid comprising at least one substantially impervious sleeve defining at least one chamber, wherein the shape of the at least one chamber is variable, the device including at least one orifice for allowing a fluid into and/or out of the at least one chamber. The mooring limb may act as a pump and/or as a damping device.
Abstract:
There is provided a Coleoptera polysaccharide degrading enzyme comprising an amino sequence which is: a) at least about 55 % identical to one or more of SEQ ID NOs:67-71; b) at least about 45 % identical to one or more of SEQ ID NOs:143-147; c) at least about 40 % identical to one or more of SEQ ID NOs:55-61; d) at least about 65 % identical to one or more of SEQ ID NOs:1-15; e) at least about 86 % identical to one or more of SEQ ID NOs:16-24; f) at least about 81 % identical to one or more of SEQ ID NOs:26-50 or 52-54; g) at least about 98% identical to one or more of SEQ ID NOs:51 or 62-66; or an enzymatically functional fragment or variant of any of these. There is also provided a method of degrading plant material comprising exposing the material to such a polysaccharide degrading enzyme.
Abstract translation:提供了一种鞘翅目多糖降解酶,其包含氨基序列,其是:a)与SEQ ID NO:67-71中的一个或多个至少约55%相同; b)与SEQ ID NO:143-147中的一个或多个至少约45%相同; c)与SEQ ID NO:55-61中的一个或多个至少约40%相同; d)与SEQ ID NO:1-15中的一个或多个至少约65%相同; e)与SEQ ID NO:16-24中的一个或多个相同至少约86%; f)与SEQ ID NO:26-50或52-54中的一个或多个至少约81%相同; g)与SEQ ID NO:51或62-66中的一个或多个至少约98%相同; 或任何这些的酶促功能片段或变体。 还提供了降解植物材料的方法,包括将材料暴露于这种多糖降解酶。
Abstract:
A method for the control of microorganisms, fungi or oomycetes in agriculture, said method comprising applying to plants or to the environment thereof, an anti-microbial, anti-fungal or anti- oomycetes effective amount of a combination of : (i) an agriculturally acceptable acidifying agent, and (ii) an agriculturally acceptable source of nitrite ions or a nitrate precursor thereof, wherein the combination of (i) and (ii) acts as a source of nitric oxide. Systems and compositions for use in this method are also described and claimed.